Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
about
Sex-based differences in cardiac ischaemic injury and protection: therapeutic implicationsActivation of a novel estrogen receptor, GPER, is cardioprotective in male and female ratsMechanistic Pathways of Sex Differences in Cardiovascular Disease.Cardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction.Development of subtype-selective oestrogen receptor-based therapeutics.Estrogen receptor activation and cardioprotection in ischemia reperfusion injury.Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist.Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in femalesAssociation of serum bisphenol a with hypertension in thai populationMechanism of cardioprotection: what can we learn from females?Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.Estrogen receptor beta does not influence ischemic tolerance in the aged female rat heart.Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.Estrogen signaling and cardiovascular disease.Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency.Selective estrogen receptor-alpha and estrogen receptor-beta agonists rapidly decrease pulmonary artery vasoconstriction by a nitric oxide-dependent mechanismEstrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries.Reduction of apoptosis and preservation of mitochondrial integrity under ischemia/reperfusion injury is mediated by estrogen receptor β.Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II.Parent-of-origin effects on cardiac response to pressure overload in mice.Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection.Gender differences in cardiac ischemic injury and protection--experimental aspects.Estrogen regulation of protein expression and signaling pathways in the heart.Cardiac ischaemic stress: cardiomyocyte Ca²⁺, sex and sex steroids.The effects of estrogen on various organs: therapeutic approach for sepsis, trauma, and reperfusion injury. Part 2: liver, intestine, spleen, and kidney.Estrogen and the female heart.Sexual dimorphisms of mRNA and miRNA in human/murine heart disease.Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.Sex Differences in Metabolic Cardiomyopathy.Animal models of wound repair: Are they cutting it?The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy.Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice.Dietary fish oil is antihypertrophic but does not enhance postischemic myocardial function in female mice.Role of wild-type estrogen receptor-beta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells.Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury.Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart.
P2860
Q26996309-9330CBBF-4D34-452E-B990-0701C5E064CCQ29347039-5F741116-A534-4BFA-A5F7-53EB1B52FC77Q30241924-D4BD8FD5-53F3-4C90-86C3-28FB32F447DCQ33803183-1705BE11-BBD4-484B-9F9C-6E2928910B03Q34216817-1592F02B-D867-421B-8489-01C448C510F1Q34447516-AC980257-1452-428B-A20E-98A1123556AFQ34779992-1E628638-B372-4CBC-B4C1-9D44DFC624A0Q35079434-3931237D-3C18-4524-B148-2C49089CC002Q35133839-8262CCC8-5DF4-41CD-BE92-442B44D3AAF0Q35166344-DFD988E3-3510-49C3-A478-8AE5DFBF08D0Q35574717-876BEBD1-36F3-406F-BDCB-CF6629D62D56Q35605843-E1B95711-99CC-4877-A118-B86CA9D7E0E0Q35900980-8A541F02-E145-4D44-95AC-93B0F1897EE2Q36099354-43D46B4E-95E2-4AE1-BB5C-B6226A9D89F3Q36844120-A6B8EDC1-3A43-41A3-8DB4-0326F89F0F87Q36977153-B47B2DD3-5B9B-4F29-A800-CF1EA3F0F80FQ37232975-F61870B4-A793-4C73-875D-2F3BBF2C3617Q37234859-28818AE9-FE24-4D8A-8480-4137A611D3E5Q37257504-3E3BC86D-823A-4129-AE69-3458E2FE7F4AQ37280726-6AB3C234-A6FA-408E-8CAA-FB5BEFEB5B87Q37290378-FABC6A98-CEE0-47B2-809D-B9C5A8D3204EQ37372380-815DE16A-04FD-40B5-A632-7809C179E3E7Q37423503-49A796E2-3EF3-4D27-8C5D-7F13FDE34BE3Q37527487-FFC50943-3A6E-4DF5-86A4-92989E24CE26Q37683880-DD3573CE-3D72-4D00-8CE0-0D203E46C6DCQ37896680-4C30AEE7-FEED-46B3-94CE-1492589D338BQ38021349-76EC6937-24BD-4E7C-B7EA-5D4F22BE4978Q38181814-8AE2BE9F-D682-4B20-A0AC-AB68B6D5E0C1Q38431290-D486E6C7-FBDF-4C5C-8123-E806AD36F8F7Q38815594-35DE615E-E782-422E-BE41-B8AECAB523DDQ39118050-C349160B-A624-4134-8621-4D77F0B07288Q39589433-A85C71DE-671E-4D89-97AF-E96527A70061Q42634564-9E6F3493-6C0F-463F-A56C-73C978447219Q46162555-EC8A56EF-EFE3-4CDD-AA66-026B395B51A1Q46775215-7ABF2FF1-EFF9-49A7-914F-F300FFB6C0E7Q47777887-B3B75567-70F1-4682-AA7E-0DDD940D00ACQ51659692-61E9626B-67BF-424B-A66C-F97EFA9C2359Q51697044-D028ADA0-A858-491E-9A04-1FFDE8F0523FQ53203297-EA4DAACD-54F0-4D13-85E6-86585B6E3C78Q54565667-C6598BD8-6198-4A38-9C72-A7A521ABE103
P2860
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
@en
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
@nl
type
label
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
@en
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
@nl
prefLabel
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
@en
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective.
@nl
P2093
P1476
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective
@en
P2093
Charles Steenbergen
Elizabeth Murphy
Ivana Nikolic
Jamie A Bell
Jennifer Collins
P304
P356
10.1016/J.YJMCC.2007.01.014
P50
P577
2007-02-06T00:00:00Z